All News
STAT+: Braced for details on Trump’s ‘most favored nation’ policy, pharma industry is still waiting
Braced for details on President Trump’s "most favored nation' policy, the pharma industry is still waiting.
Read MoreRFK Jr announces new panel of vaccine advisers after firing entire previous team
US health secretary had abruptly laid off 17 sitting members of independent body and appointed eight new onesRobert Kennedy Jr, the US health secretary, named new members to serve on a key panel of va
Read MoreRheumatology Indication Looks Promising for Efgartigimod
(MedPage Today) -- BARCELONA -- A drug targeting immunoglobulin G (IgG) currently approved for myasthenia gravis and chronic inflammatory demyelinating polyneuropathy (CIDP) now looks like it could
Read MoreRFK Jr. Names Replacements for CDC Vaccine Panel
(MedPage Today) -- HHS Secretary Robert F. Kennedy Jr.
Read MoreHundreds of Laid-Off CDC Employees Are Being Reinstated
(MedPage Today) -- More than 460 laid-off employees at the nation's top public health agency received notices Wednesday that they are being reinstated, according to a union representing the workers.
Read MoreDementia, Stroke, Depression Linked to Biological Aging Marker
(MedPage Today) -- Shorter leukocyte telomere length -- a marker of biological aging -- was tied to a higher risk of age-related brain disease, but modifiable risk factors appeared to mitigate it
Read MoreRFK Jr. names new members of CDC’s vaccine advisory panel
RFK Jr. Kennedy Jr. announced the new members of the panel of experts that advises the CDC on vaccine policy.
Read MoreEMTALA Still Supports Emergency Abortion Care — No Matter What Memo You Read
(MedPage Today) -- On June 3, 2025, the Trump administration rescinded Biden-era federal guidance that affirmed the Emergency Medical Treatment and Active Labor Act (EMTALA) and specifically reinforc
Read MoreOncology Community Rallies, Rails Against 'Draconian' Budget Cuts for NIH, NCI
(MedPage Today) -- The oncology community has sounded the alarm over the Trump administration's 2026 budget proposal, which includes near-40% cuts in funding for the NIH and National Cancer Institute
Read MoreNext-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer
(MedPage Today) -- The FDA approved taletrectinib (Ibtrozi) -- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment of adults with locally advanced or metastatic ROS1-
Read More